17beta-HSD1 and STS inhibitors

Details for Australian Patent Application No. 2006251154 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Pirkkala, Lila; Messinger, Josef; Husen, Bettina; Thole, Heinrich-Hubert; Weske, Michael; Koskimies, Pasi

Agent Watermark

Pub. Number AU-B-2006251154

PCT Pub. Number WO2006/125800

Priority 05104534.2 26.05.05 EP

Filing date 24 May 2006

Wipo publication date 30 November 2006

Acceptance publication date 28 June 2012

International Classifications

C07J 41/00 Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

A61K 31/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/58 - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 5/32 Drugs for disorders of the endocrine system

C07J 43/00 Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

C07J 71/00 Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/125800 Priority application(s): WO2006/125800

28 June 2012 Application Accepted

  Published as AU-B-2006251154

25 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006251157-Thiazole derivatives and use thereof

2006251148-Motorized pipette